FREE EDUCATIONAL SEMINARS
Focus on Serology: 29 June 2011 & Focus On Driving Efficiencies - Assay Partners for the Future:30 June 2011.
Roche are delighted to invite you to participate in their forthcoming educational days to be held on 29 & 30 June 2011 in central London (close to London Victoria Station).
Agendas are shown below, to reserve your place please email your name, position, address, and telephone details to [email protected] (or fax on 01444 256203), stating which day(s) you would like to attend. Places are limited and will be allocated on a first come first served basis.
Focus on Serology: 29 June
Overview of Serology Testing to-date (with additional focus on HIV) Dr. Mark Atkins, Consultant Virologist, Chelsea and Westminster Hospital.
Pegasys in Hepatitis B - Personalized Healthcare in Chronic hepatitis B Patients Dr. Patrick Kennedy, London.
Platform Consolidation - A Serologist’s Perspective Jayne Harwood, Consultant Microbiologist, Freeman Hospital.
TORCH, Diagnosis & Management, Dr. Liliane Grangeot-Keros, Antoine Béclère Hospital, France Development of New Serological Infectious Diseases Tests, Dr. Roland Hofweber, Roche, Penzberg, Germany.
Focus On Driving Efficiencies - Assay Partners for the Future: 30 June
Increasing Efficiency/Productivity in the NHS - Implementing the QIPP Agenda(Focus on Pathology/Diagnostic Testing), Steve Graham, Department of Health.
A Need for Harmonisation of Cardiac Biomarkers in Clinical Practice (HighSensitive Troponin-T and NT proBNP), Dr. Martin Meyers, Consultant Chemical Biochemist and Clinical Director, Lancashire Teaching Hospitals NHS Foundation Trust.
Vitamin D (Benefits of consolidation onto an automated immunoassay systemand evaluation of the Roche Vitamin D Total assay), John Fenwick, Laboratory Manager for Queen Elizabeth Hospital, Gateshead HbA1c (Achieving).
HbA1c testing on an immunoassay platform), Dr Sihe Wang, Section Head, Clinical Biochemistry, Cleveland Clinic, USA.
Haematinics (Consolidating anaemia testing on an automated immunoassayanalyser) Daren Jose, Head Biomedical Scientist & Laboratory Manager, Clinical Biochemistry Department, Poole Hospital NHS Foundation Trust.
The Novel Dual Marker Combination HE4 and CA125 (Supporting improvements in ovarian cancer diagnosis and therapy in women with pelvic mass), Achim Escherich, Roche Global Assay Development Team.
The seminars start at 09.30 and finish between 15.15 and 16.00. Please note that places are allocated at Roche’s discretion and application does not guarantee that a place will be made available.
